What is a stock summary page? Click here for an overview.
Business Description
Ourofino SA
ISIN : BROFSAACNOR7
Compare
Compare
Traded in other countries / regions
OFSA3.Brazil IPO Date
2014-10-01Description
Ourofino SA is engaged in research, development, production and sales of medicines, vaccines and other veterinary products. The company's reportable segments are Production animals, Companion animals, and International operations. It generates maximum revenue from the Production animals segment. The product portfolio includes Anticoccidials, Antimastitics, Biological, Ectoparasiticides, Endectocides, and others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.62 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.5 | |||||
| Debt-to-EBITDA | 1.52 | |||||
| Interest Coverage | 6.13 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.92 | |||||
| Beneish M-Score | -1.97 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.3 | |||||
| 3-Year EBITDA Growth Rate | 12.6 | |||||
| 3-Year EPS without NRI Growth Rate | 6 | |||||
| 3-Year Book Growth Rate | 5.6 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.13 | |||||
| 9-Day RSI | 52.98 | |||||
| 14-Day RSI | 58.12 | |||||
| 3-1 Month Momentum % | 21.19 | |||||
| 6-1 Month Momentum % | -1.86 | |||||
| 12-1 Month Momentum % | -2.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.06 | |||||
| Quick Ratio | 2.17 | |||||
| Cash Ratio | 0.8 | |||||
| Days Inventory | 173.2 | |||||
| Days Sales Outstanding | 91.49 | |||||
| Days Payable | 68.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.52 | |||||
| Dividend Payout Ratio | 0.36 | |||||
| 3-Year Dividend Growth Rate | 8 | |||||
| Forward Dividend Yield % | 0.42 | |||||
| 5-Year Yield-on-Cost % | 20.04 | |||||
| Shareholder Yield % | 3.91 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.52 | |||||
| Operating Margin % | 18.85 | |||||
| Net Margin % | 13.11 | |||||
| FCF Margin % | 2.85 | |||||
| ROE % | 18.83 | |||||
| ROA % | 10.22 | |||||
| ROIC % | 16.25 | |||||
| 3-Year ROIIC % | 20.41 | |||||
| ROC (Joel Greenblatt) % | 29.42 | |||||
| ROCE % | 19.69 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 8.92 | |||||
| Forward PE Ratio | 10.93 | |||||
| PE Ratio without NRI | 8.77 | |||||
| Shiller PE Ratio | 15.34 | |||||
| PEG Ratio | 0.6 | |||||
| PS Ratio | 1.17 | |||||
| PB Ratio | 1.59 | |||||
| Price-to-Tangible-Book | 1.84 | |||||
| Price-to-Free-Cash-Flow | 40.93 | |||||
| Price-to-Operating-Cash-Flow | 16.21 | |||||
| EV-to-EBIT | 6.42 | |||||
| EV-to-EBITDA | 5.44 | |||||
| EV-to-Revenue | 1.31 | |||||
| EV-to-FCF | 46.63 | |||||
| Price-to-GF-Value | 0.92 | |||||
| Price-to-Projected-FCF | 0.96 | |||||
| Price-to-DCF (Earnings Based) | 0.71 | |||||
| Price-to-DCF (FCF Based) | 3.55 | |||||
| Price-to-Median-PS-Value | 0.47 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.7 | |||||
| Price-to-Graham-Number | 0.85 | |||||
| Price-to-Net-Current-Asset-Value | 4.54 | |||||
| Earnings Yield (Greenblatt) % | 15.57 | |||||
| FCF Yield % | 2.44 | |||||
| Forward Rate of Return (Yacktman) % | 16.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ourofino SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 1,024.792 | ||
| EPS (TTM) (R$) | 2.498 | ||
| Beta | 1.26 | ||
| 3-Year Sharpe Ratio | -0.06 | ||
| 3-Year Sortino Ratio | -0.1 | ||
| Volatility % | 36.76 | ||
| 14-Day RSI | 58.12 | ||
| 14-Day ATR (R$) | 0.56466 | ||
| 20-Day SMA (R$) | 22.283 | ||
| 12-1 Month Momentum % | -2.76 | ||
| 52-Week Range (R$) | 16.01 - 23.4 | ||
| Shares Outstanding (Mil) | 53.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ourofino SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ourofino SA Stock Events
| Event | Date | Price (R$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ourofino SA Frequently Asked Questions
What is Ourofino SA(BSP:OFSA3)'s stock price today?
The current price of BSP:OFSA3 is R$22.27. The 52 week high of BSP:OFSA3 is R$23.40 and 52 week low is R$16.01.
When is next earnings date of Ourofino SA(BSP:OFSA3)?
The next earnings date of Ourofino SA(BSP:OFSA3) is 2025-05-09 Est..
Does Ourofino SA(BSP:OFSA3) pay dividends? If so, how much?
The Dividend Yield %  of Ourofino SA(BSP:OFSA3) is 4.52% (As of Today), Highest Dividend Payout Ratio of Ourofino SA(BSP:OFSA3) was 0.66. The lowest was 0.11. And the median was 0.26. The  Forward Dividend Yield % of Ourofino SA(BSP:OFSA3) is 0.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers